Edward Smith - Dec 6, 2023 Form 4 Insider Report for Benitec Biopharma Inc. (BNTC)

Role
Director
Signature
/s/ Edward Smith
Stock symbol
BNTC
Transactions as of
Dec 6, 2023
Transactions value $
$0
Form type
4
Date filed
12/7/2023, 07:57 PM
Previous filing
Dec 9, 2022
Next filing
Dec 11, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNTC Options (right to buy) Award $0 +35K $0.00 35K Dec 6, 2023 Common Stock 35K $3.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options will vest in three substantially equal installments on the day prior to each of the Issuer's next three annual stockholder meetings occurring immediately following the date of grant.